Physical Activity for Alzheimer's Disease
(RAATE-MCI Trial)
Trial Summary
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Physical activity program for Alzheimer's Disease?
Is physical activity safe for people with Alzheimer's disease?
How is the physical activity program treatment for Alzheimer's disease different from other treatments?
The physical activity program for Alzheimer's disease is unique because it focuses on improving patients' functional abilities and independence through regular exercise, which can be done at home or in care settings, making it more accessible and easier for caregivers to manage compared to traditional medical treatments.124910
What is the purpose of this trial?
The RAATE-MCI proposal is designed to determine the effects of physical activity on risk factors for Alzheimer's Disease in older African American adults. The study will compare a physical activity program to an active control group. RAATE-MCI is a 52-week randomized controlled trial. 144 African American adults aged 60 and older will be recruited.
Research Team
Robert L Newton, Jr., PhD
Principal Investigator
Pennington Biomedical Research
Owen Carmichael, PhD
Principal Investigator
Pennington Biomedical Research
Eligibility Criteria
The RAATE-MCI trial is for African American adults aged 60 or older who self-identify as such, are willing to be randomly assigned to groups, can attend sessions and travel within the study area for a year. They must be physically able to exercise but not currently active, have mild cognitive impairment without severe dementia, and agree to data use after the study.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are assigned to either a physical activity intervention or a successful aging group for 52 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Physical activity program
- Successful Aging
Find a Clinic Near You
Who Is Running the Clinical Trial?
Pennington Biomedical Research Center
Lead Sponsor
National Institute on Aging (NIA)
Collaborator